In this report, we describe the molecular characteristics of gliomas or glioneuronal tumors in five individuals with NS associated with PTPN11. All five individuals also had somatic alterations which led to activation of the RAS/MAPK and PI3K/AKT signaling pathways (Table 2, Figures 6, 7). The gene discussed is PTPN11; the disease is central nervous system cancer.